The clinical and immunogenetic characteristics of adult-onset type 1 diabetes mellitus in Korea

Acta Diabetologica

Volumn 44, Issue 2, 2007, Pages 45-54

  Kim, C S ^a   Song, M K ^a   Park, J S ^a   Cho, M H ^a   Kim, H J ^a   Nam, J S ^a   Kang, E S ^a   Ahn, C W ^a   Cha, B S ^a   Lee, E G ^a   Lim, S K ^a   Kim, K R ^a   Lee, H C ^a   Huh, K B ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Adult onset type 1 DM; Anti GAD antibody; HLA DQ; HLA DR; LADA

Indexed keywords

C PEPTIDE; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; IA ANTIBODY; INSULIN;

ADULT; AGE DISTRIBUTION; ALLELE; ANTIBODY DETECTION; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; ENVIRONMENTAL FACTOR; FEMALE; GENOTYPE; HEREDITY; HUMAN; IMMUNOGENETICS; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; KETONURIA; KOREA; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE OF ONSET; BODY MASS INDEX; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNOGENETICS; KOREA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34249702823     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0241-y     Document Type: Article

References (48)

1. Eisenbarth GS (1986) Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 314:1360-1368
2. Eisenbarth GS (1987) Genes, generator of diversity, glycol-conjugates, and autoimmune beta-cell insufficiency in type 1 diabetes. Diabetes 36:355-364
3. Bach JF (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15:516-534
4. Risch N (1987) Assessing the role of HLA-linked and unlinked determinants of disease. Am J Hum Genet 40:1-14
5. Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85:291-297
6. Landin-Olsson M, Nilsson KO, Lernmark A, Sundkvist G (1990) Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568
7. Lernmark A, Baekkeskov S (1981) Islet cell antibodies-theoretical and practical implications. Diabetologia 21:431-435
8. Aanstoot HJ, Sigurdsson E, Jaffe M, Shi Y, Christgau S, Grobbee D, Bruining GJ, Molenaar JL, Hofman A, Baekkeskov S (1994) Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37:917-924
9. Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG (1997) Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20:965-970
10. Wiest-Ladenburger U, Hartmann R, Hartmann U, Berling K, Bohm BO, Richter W (1997) Combined analysis and single step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes 46:565-571
11. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA (1994) Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303
12. Kasuga A, Ozawa Y, Maruyama T, Ishihara T, Amemiya S, Saruta T (1997) Autoantibody against IA-2 improves the test sensitivity for insulin-dependent diabetes mellitus in Japanese patients of child onset. Endocr J 44:485-491
13. Thai AC, Ng WY, Loke KY, Lee WR, Lui KF, Cheah JS (1997) Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM. Diabetologia 40:1425-1430
14. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K (1987) Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36:510-517
15. Tuomi T, Zimmet P, Rowley MJ, Min HK, Vichayanrat A, Lee HK, Rhee BD, Vannasaeng S, Humphrey AR, Mackay IR (1995) Differing frequency of autoantibodies to glutamic acid decarboxylase among Koreans, Thais, and Australians with diabetes mellitus. Clin Immunol Immunopathol 74:202-206
16. Lee HC, Cha BS, Nam MS, Song YD, Lim SK, Kim DH, Huh KB, Koh Y (1995) Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea. Korean J Intern Med 10:1-9
17. Kobayashi T (1994) Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM-the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24[Suppl]:S95-S99
18. Schiel R, Muller UA (2000) GAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? Diabetes Res Clin Pract 49:33-40
19. Gambelunghe G, Forini F, Laureti S, Murdolo G, Toraldo G, Santeusanio F, Brunetti P, Sanjeevi CB, Falorni A (2000) Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 52:565-573
20. Shiau MY, Tsai ST, Hwang J, Wu CY, Chang YH (2000) Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan. Eur J Endocrinol 142:577-585
21. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, Karlsen AE, Boel E, Michelsen B, Lernmark A (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344-350
22. Melton LJ 3rd, Palumbo PJ, Chu CP (1983) Incidence of diabetes mellitus by clinical type. Diabetes Care 6:75-86
23. Karjalainen J, Salmela P, Ilonen J, Surgel H, Knip M (1989) A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881-886
24. Vandewalle C, Falorni A, Svanholm S, Lernmark A, Pipeleers D, Gorus F (1995) High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab 80:846-851
25. Park YS, Lee HK, Min HK, Rowley M, Mackay I, Zimmet P, McCarthy B, McCanlies E, Dorman J, Trucco M (1996) The low prevalence of immunogenetic markers in Korean adultonset IDDM patients. Diabetes Care 19:241-245
26. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E (1995) Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426
27. Hawa M, Rowe R, Lan M, Notkins A, Pozzilli P, Chrisitie M, Leslie R (1997) Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46:1270-1275
28. Kawasaki E, Takino H, Yano M, Uotani S, Mastsumoto K, Yamaguchi Y, Akazawa S, Nagataki S (1994) Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies. J Autoimmun 7:791-802
29. Lohmann T, Seissler J, Verlohren H, Schroder S, Rotger J, Dahn K, Morgenthaler N, Scherbaum W (1997) Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 20:524-529
30. Vandewalle C, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Auwera B, Kaufman L, Schuit F, Pipeleers D, Gours F (1997) Associations of GAD65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care 20:1547-1557
31. Platz P, Jakobson BK, Morling N, Ryder LP, Svejgaard A, Thomson M, Christy M, Kromann H, Benn J, Nerup J, Green A (1981) HLA-D and-DR antigens in genetic analysis of insulin dependent diabetes mellitus. Diabetologia 21:108-115
32. Todd JA, Fukui Y, Jitagawa T, Sasazuki T (1990) The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc Natl Acad Sci U S A 87:1094-1098
33. Serjeantson S, Kohonen-Corish M, Rowley M, Mackay I, Knowles W, Zimmet P (1992) Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:996-1001
34. Awata T, Kanazawa Y (1994) Genetic markers for insulindependent diabetes mellitus in Japanese. Diabetes Res Clin Pract 24[Suppl]:S83-S87
35. Hawkins B, Lam K, Ma J, Low L, Cheung P, Serjeantson S, Yeung R (1987) Strong association of HLA-DR3/DRw9 heterozygosity with early-onset insulin-dependent diabetes mellitus in Chinese. Diabetes 36:1297-1300
36. Khalil I, Auriol L, Gobet M, Morin L, Lepage V, Deschamps I, Park M, Degos L, Galibert F, Hors J (1990) A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 85:1315-1319
37. Reijonen H, Ilonen J, Knip M, Akerblom K (1991) HLADQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland. Diabetes 40:1640-1644
38. Todd J, Bell J, McDevitt H (1987) HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599-604
39. Awata T, Kuzuya T, Mastuda A, Iwamoto Y, Kanazawa Y, Okuyama M, Juhi T (1990) High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 39:266-269
40. Ikegami H, Tahara Y, Cha T, Yamato E, Ogihara T, Noma Y, Shima K (1990) Aspartic acid at position 57 of the HLA-DQ beta chain is not protective against insulin-dependent diabetes mellitus in Japanese people. J Autoimmun 3:167-174
41. Buzzetti R, Nistico L, Osborn J, Giovannini C, Chersi A, Sorrentino R (1993) HLA-DQA1 and DQB1 gene polymorphisms in type I diabetic patients from central Italy and their use for risk prediction. Diabetes 42:1173-1178
42. Gutierrez-Lopez MD, Bertera S, Chantres MT, Vavssori C, Dorman JS, Trucci M, Serrano-Rios M (1992) Susceptibility to type 1 diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQα Arg52 and HLA DQβnon-Asp 57 alleles. Diabetologia 35:583-588
43. Nepom GT, Erlich H (1991) MHC class-II molecules and autoimmunity. Annu Rev Immunol 9:493-525
44. Thorsby E, Ronningen K (1993) Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:371-377
45. Groop L, Miettinen A, Groop P, Meri S, Koskimies S, Bottazzo G (1988) Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes 37:99-103
46. Vandewalle C, Decraene T, Schuit F, Leeuw I, Pipeleers D, Gorus F (1993) Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry. Diabetologia 36:1155-1162
47. Vandewalle C, Coeckelber M, Leeuw I, Caju M, Schiut F, Pipeleers D, Gorus F (1997) Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry. Diabetes Care 20:1556-1561
48. Sugihara S, Sakamai T, Konda S, Murata A, Wataki K, Kobayashi Y, Minamitani K, Miyamoto S, Sasaki N, Niimi H (1997) Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes 46:1893-1897